Ontology highlight
ABSTRACT: Background
Bioresorbable scaffolds have been associated with inferior outcomes compared to contemporary permanent metallic drug-eluting stents (DES) for percutaneous coronary intervention, particularly within the initial years after implantation; however, their long-term performance remains uncertain. This study aimed to evaluate the long-term outcomes of Swedish patients treated with Absorb bioresorbable scaffolds (Abbott) vs contemporary DES, assessing device-related complications and examining potential late benefits. The findings seek to clarify the balance between early risks and long-term advantages of bioresorbable scaffolds in clinical practice.Methods
Complete data from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR) was used to identify all patie
SUBMITTER: Saidi-Seresht S
PROVIDER: S-EPMC12485528 | biostudies-literature | 2025 Sep
REPOSITORIES: biostudies-literature